Interaction of the Hereditary Hemochromatosis Protein HFE with Transferrin Receptor 2 Is Required for Transferrin-Induced Hepcidin Expression

Cell Metabolism

Volumn 9, Issue 3, 2009, Pages 217-227

  Gao, Junwei ^a   Chen, Juxing ^a   Kramer, Maxwell ^a   Tsukamoto, Hidekazu ^b,c   Zhang, An Sheng ^a   Enns, Caroline A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HUMDISEASE

Indexed keywords

HEPCIDIN; HFE PROTEIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOPLASM; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IRON BALANCE; IRON BLOOD LEVEL; IRON OVERLOAD; IRON TRANSPORT; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ANTIGENS, CD; ANTIMICROBIAL CATIONIC PEPTIDES; CELLS, CULTURED; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMEOSTASIS; HUMANS; IRON; LIVER; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; RECEPTORS, TRANSFERRIN; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; TRANSFERRIN;

EID: 60649103774     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.01.010     Document Type: Article

References (57)

1. Ahmad K.A., Ahmann J.R., Migas M.C., Waheed A., Britton R.S., Bacon B.R., Sly W.S., and Fleming R.E. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol. Dis. 29 (2002) 361-366
2. Ajioka R.S., and Kushner J.P. Hereditary hemochromatosis. Semin. Hematol. 39 (2002) 235-241
3. Bennett M.J., Lebron J.A., and Bjorkman P.J. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403 (2000) 46-53
4. Bondi A., Valentino P., Daraio F., Porporato P., Gramaglia E., Carturan S., Gottardi E., Camaschella C., and Roetto A. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload. Haematologica 90 (2005) 1161-1167
5. Bothwell T.H., and MacPhail A.P. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin. Hematol. 35 (1998) 55-71
6. Braiterman L.T., Heffernan S., Nyasae L., Johns D., See A.P., Yutzy R., McNickle A., Herman M., Sharma A., Naik U.P., and Hubbard A.L. JAM-A is both essential and inhibitory to development of hepatic polarity in WIF-B cells. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008) G576-G588
7. Bridle K.R., Frazer D.M., Wilkins S.J., Dixon J.L., Purdie D.M., Crawford D.H., Subramaniam V.N., Powell L.W., Anderson G.J., and Ramm G.A. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361 (2003) 669-673
8. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., Majorano N., Totaro A., and Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25 (2000) 14-15
9. Chen J., Chloupkova M., Gao J., Chapman-Arvedson T.L., and Enns C.A. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions. J. Biol. Chem. 282 (2007) 36862-36870
10. Cherry J., Nieuwenhuijsen B.W., Kaftan E.J., Kennedy J.D., and Chanda P.K. A modified method for PCR-directed gene synthesis from large number of overlapping oligodeoxyribonucleotides. J. Biochem. Biophys. Methods 70 (2008) 820-822
11. De Domenico I., McVey Ward D., and Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 9 (2008) 72-81
12. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., and Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Biol. Cell 7 (1987) 725-737
13. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo Jr. R., Ellis M.C., Fullan A., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13 (1996) 399-408
14. Feder J.N., Tsuchihashi Z., Irrinki A., Lee V.K., Mapa F.A., Morikang E., Prass C.E., Starnes S.M., Wolff R.K., Parkkila S., et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272 (1997) 14025-14028
15. Feder J.N., Penny D.M., Irrinki A., Lee V.K., Lebron J.A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P.J., and Schatzman R.C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA 95 (1998) 1472-1477
16. Feng Y., and Longmore G.D. The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complex. Mol. Biol. Cell 25 (2005) 4010-4022
17. Gao J., Zhao N., Knutson M.D., and Enns C.A. The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of zip14 in hepG2 cells. J. Biol. Chem. 283 (2008) 21462-21468
18. Gehrke S.G., Kulaksiz H., Herrmann T., Riedel H.D., Bents K., Veltkamp C., and Stremmel W. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to the serum transferrin saturation and to non-transferrin-bound iron. Blood 102 (2003) 371-376
19. Giannetti A.M., Snow P.M., Zak O., and Bjorkman P.J. Mechanism for multiple ligand recognition by the human transferrin receptor. PLoS Biol. 1 (2003) 341-350
20. Goswami T., and Andrews N.C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 281 (2006) 28494-28498
21. Holmstrom P., Dzikaite V., Hultcrantz R., Melefors O., Eckes K., Stal P., Kinnman N., Smedsrod B., Gafvels M., and Eggertsen G. Structure and liver cell expression pattern of the HFE gene in the rat. J. Hepatol. 39 (2003) 308-314
22. Ihrke G., Neufeld E.B., Meads T., Shanks M.R., Cassio D., Laurent M., Schroer T.A., Pagano R.E., and Hubbard A.L. WIF-B cells: an in vitro model for studies of hepatocyte polarity. J. Cell Biol. 123 (1993) 1761-1775
23. Johnson M.B., and Enns C.A. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104 (2004) 4287-4293
24. Kawabata H., Yang R., Hirama T., Vuong P.T., Kawano S., Gombart A.F., and Koeffler H.P. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 274 (1999) 20826-20832
25. Kawabata H., Fleming R.E., Gui D., Moon S.Y., Saitoh T., O'Kelly J., Umehara Y., Wano Y., Said J.W., and Koeffler H.P. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105 (2005) 376-381
26. Kim D.S., Ahn S.K., Yoon J.H., Hong S.H., Kim K.E., Maurer R.A., and Park S.D. Involvement of a cAMP-responsive DNA element in mediating TRH responsiveness of the human thyrotropin alpha-subunit gene. Mol. Endocrinol. 8 (1994) 528-536
27. Konieczko E.M., Ralston A.K., Crawford A.R., Karpen S.J., and Crawford J.M. Enhanced Na+-dependent bile salt uptake by WIF-B cells, a rat hepatoma hybrid cell line, following growth in the presence of a physiological bile salt. Hepatology 27 (1998) 191-199
28. Krijt J., Niederkofler V., Salie R., Sefc L., Pelichovska T., Vokurka M., and Necas E. Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice. Blood Cells Mol. Dis. 39 (2007) 92-95
29. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
30. Lebron J.A., and Bjorkman P.J. The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis. J. Mol. Biol. 289 (1999) 1109-1118
31. Lebron J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., and Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93 (1998) 111-123
32. Levy J.E., Montross L.K., Cohen D.E., Fleming M.D., and Andrews N.C. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 94 (1999) 9-11
33. Lin L., Valore E.V., Nemeth E., Goodnough J.B., Gabayan V., and Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110 (2007) 2182-2189
34. Martin C.S., Wight P.A., Dobretsova A., and Bronstein I. Dual luminescence-based reporter gene assay for luciferase and beta-galactosidase. Biotechniques 21 (1996) 520-524
35. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., Trenor C.C., Gasparini P., Andrews N.C., and Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108 (2001) 619-623
36. Muckenthaler M., Roy C.N., Custodio A.O., Minana B., deGraaf J., Montross L.K., Andrews N.C., and Hentze M.W. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34 (2003) 102-107
37. Muckenthaler M.U., Rodrigues P., Macedo M.G., Minana B., Brennan K., Cardoso E.M., Hentze M.W., and de Sousa M. Molecular analysis of iron overload in beta2-microglobulin-deficient mice. Blood Cells Mol. Dis. 33 (2004) 125-131
38. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
39. Nicolas G., Viatte L., Lou D.Q., Bennoun M., Beaumont C., Kahn A., Andrews N.C., and Vaulont S. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34 (2003) 97-101
40. Nies A.T., Cantz T., Brom M., Leier I., and Keppler D. Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF-B. Hepatology 28 (1998) 1332-1340
41. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., Andres L., MacFarlane J., Sakellaropoulos N., Politou M., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36 (2004) 77-82
42. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276 (2001) 7811-7819
43. Robb A., and Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104 (2004) 4294-4299
44. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., Loukopoulos D., and Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33 (2003) 21-22
45. Schmidt P.J., Toran P.T., Giannetti A.M., Bjorkman P.J., and Andrews N.C. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 7 (2008) 205-214
46. Verga Falzacappa M.V., Casanovas G., Hentze M.W., and Muckenthaler M.U. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J. Mol. Med. 86 (2008) 531-540
47. Vogt T.M., Blackwell A.D., Giannetti A.M., Bjorkman P.J., and Enns C.A. Heterotypic interactions between transferrin receptor and transferrin receptor 2. Blood 101 (2003) 2008-2014
48. Vujic Spasic M., Kiss J., Herrmann T., Galy B., Martinache S., Stolte J., Grone H.J., Stremmel W., Hentze M.W., and Muckenthaler M.U. Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab. 7 (2008) 173-178
49. Waheed A., Parkkila S., Saarnio J., Fleming R.E., Zhou X.Y., Tomatsu S., Britton R.S., Bacon B.R., and Sly W.S. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc. Natl. Acad. Sci. USA 96 (1999) 1579-1584
50. Wallace D.F., Summerville L., and Subramaniam V.N. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload. Gastroenterology 132 (2007) 301-310
51. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
52. West Jr. A.P., Giannetti A.M., Herr A.B., Bennett M.J., Nangiana J.S., Pierce J.R., Weiner L.P., Snow P.M., and Bjorkman P.J. Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J. Mol. Biol. 313 (2001) 385-397
53. Wilson I.A., and Bjorkman P.J. Unusual MHC-like molecules: CD1, Fc receptor, the hemochromatosis gene product, and viral homologs. Curr. Opin. Immunol. 10 (1998) 67-73
54. Zhang A.S., Davies P.S., Carlson H.L., and Enns C.A. Mechanisms of HFE-induced regulation of iron homeostasis: Insights from the W81A HFE mutation. Proc. Natl. Acad. Sci. USA 100 (2003) 9500-9505
55. Zhang A.S., Xiong S., Tsukamoto H., and Enns C.A. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 103 (2004) 1509-1514
56. Zhang A.S., Anderson S.A., Meyers K.R., Hernandez C., Eisenstein R.S., and Enns C.A. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J. Biol. Chem. 282 (2007) 12547-12556
57. Zhou X.Y., Tomatsu S., Fleming R.E., Parkkila S., Waheed A., Jiang J., Fei Y., Brunt E.M., Ruddy D.A., Prass C.E., et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 95 (1998) 2492-2497